Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT

Launched by UNIVERSITY OF ZURICH · Apr 9, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a special type of CT scan called PCD-CT, which uses ultra low doses of radiation and a contrast agent called Iomeron 400. The goal is to see how well this method works for detecting lung issues like pulmonary nodules (small growths in the lungs), pneumonia, and other lung conditions while minimizing radiation exposure to patients.

To participate in this trial, you need to be between 65 and 74 years old and require a CT scan for checking lung nodules or pneumonia. Unfortunately, people under 18 or those with a body mass index (BMI) over 30 cannot join. If you qualify and decide to take part, you can expect to undergo a CT scan using the new low-dose method, which aims to keep you safe while still providing important information about your lung health. This study is currently recruiting participants, so if you or someone you know fits the criteria, it might be a good opportunity to contribute to important research!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • CT SCAN for pulmonary nodule detection/follow up
• • CT SCAN for pneumonia detection/follow up
• Exclusion Criteria:
• • under 18
• • BMI over 30